Myriad launches hereditary cancer detection tool

Myriad launches hereditary cancer detection tool

Myriad launches hereditary cancer detection tool

07 September 2017 | News

riskScore is an algorithm designed to combine genetic markers with a patient’s family and clinical history.

Courtesy- Shuttershock

US-based molecular diagnostics firm Myriad Genetics has introduced a new medical tool, riskScore, to support its myRisk test developed for hereditary cancer.

riskScore is an algorithm designed to combine genetic markers with a patient’s family and clinical history to quantify the risk of breast cancer development.